Under construction – not a live service
Sign in
Not yet taking people in United StatesNo phase

Ear nerve stimulation in young stroke survivors doing occupational therapy

Tests how well young stroke survivors tolerate gentle ear nerve stimulation.

Plain-language title generated from the registry record
Registry title: Tolerability of Transcutaneous Vagal Nerve Stimulation

Key facts

Where
Houston, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 13 and 21 years old?

Source: NCT07735234, who can take part

Where in United States

  • The University of Texas Health Science Center at HoustonHouston, United StatesNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
The University of Texas Health Science Center, Houston
Trial code
NCT07735234
Record updated
29 July 2026
Original description
The purpose of this study is to assess the feasibility and tolerability of transcutaneous auricular vagus nerve stimulation (taVNS) in childhood stroke survivors undergoing bi-manual occupational therapy.Read full original descriptionShow less

Tolerability of Transcutaneous Auricular Vagus Nerve Stimulation in Pediatric Stroke Survivors 1Tolerability of Transcutaneous Auricular Vagus Nerve Stimulation in Pediatric Stroke Survivors 1

The purpose of this study is to assess the feasibility and tolerability of transcutaneous auricular vagus nerve stimulation (taVNS) in childhood stroke survivors undergoing bi-manual occupational therapy.

Inclusion: Childhood stroke survivor - either arterial ischemic stroke or intracerebral hemorrhage; Stroke must be childhood onset, defined as occurring day 29 of life to 18 years of age (per the American Heart Association's definition of childhood stroke); 6 months or greater from stroke onset; Arm impairment, defined as pediatric stroke outcome measure of 1 or greater of affected arm; Affected arm Fugl-Meyer score of 60 or lower; Able to participate in occupational therapy sessions.

Exclusion: Craniectomy without replacement of bone flap. Patients who underwent craniectomy will need the bone flap reattached prior to participation; Presence of cranial metal implants or implant device that could be affected by taVNS: cochlear implant, implanted brain stimulator, or programmable ventriculoperitoneal shunt.

ClinicalTrials.gov NCT07735234